Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Change in Inventory (2020 - 2025)

Celularity (CELU) has disclosed Change in Inventory for 6 consecutive years, with -$2.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Change in Inventory fell 358.65% to -$2.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$9.2 million, a 43.16% decrease, with the full-year FY2024 number at -$6.3 million, down 826.47% from a year prior.
  • Change in Inventory was -$2.3 million for Q3 2025 at Celularity, up from -$3.7 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $9.0 million in Q2 2022 to a low of -$3.7 million in Q2 2025.
  • A 5-year average of $493315.8 and a median of $61000.0 in 2022 define the central range for Change in Inventory.
  • Peak YoY movement for Change in Inventory: skyrocketed 2692.16% in 2021, then crashed 1313.11% in 2023.
  • Celularity's Change in Inventory stood at $2.6 million in 2021, then plummeted by 97.69% to $61000.0 in 2022, then plummeted by 1313.11% to -$740000.0 in 2023, then increased by 14.73% to -$631000.0 in 2024, then plummeted by 265.61% to -$2.3 million in 2025.
  • Per Business Quant, the three most recent readings for CELU's Change in Inventory are -$2.3 million (Q3 2025), -$3.7 million (Q2 2025), and -$2.6 million (Q1 2025).